Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:51 2024-07-15 am EDT 5-day change 1st Jan Change
1,586 INR +0.56% Intraday chart for Sun Pharmaceutical Industries Ltd. +1.13% +25.94%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Bain-backed Emcure Pharma's $234 million India IPO draws $11 billion in bids RE
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says RE
Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner, CGST and Central Excise, Mumbai CI
Sun Pharma Completes Taro Pharmaceutical Industries Merger MT
Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately CI
Sun Pharmaceutical Industries Limited Announces Results from A Phase 1, Multiple Ascending-Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Gl0034 (Utreglutide) in Obese Adults CI
Japanese Stocks End Little Changed After Three-Day Winning Streak on Inflation and Yen Woes MT
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India RE
Sun Pharma Signs Deal with Japan's Takeda to Commercialize Vonoprazan in India MT
Sun Pharma Signs Non-Exclusive Patent Licensing Agreement with Takeda for Introducing Novel Gastrointestinal Drug, Voltapraz in India CI
Gains in Metal, Realty Stocks Help Indian Equities End Higher MT
Sun Pharmaceutical Industries Gets US FDA's Warning Letter for Dadra, India Facility MT
INDIA STOCKS-Indian shares muted as financials, pharma stocks weigh RE
INDIA STOCKS-Indian shares open marginally higher led by private banks RE
Sun Pharmaceutical to Acquire 9.6% Stake in Genome Software Haystack Analytics MT
Sun Pharmaceutical Industries Limited agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million. CI
Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner of State Tax CT& GST -Territorial Range -Bhubaneswar CI
Philogen, Inc. and Sun Pharmaceutical Industries Limited Announces Results of the Phase III PIVOTAL Trial of Nidlegy in Melanoma CI
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research RE
Sun Pharma to Pursue M&A CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical MT
Indian Equities Hit Intraday Record Highs on Thursday, Lifted by Easing Poll Worries, Strong Domestic Buying MT
Sun Pharmaceutical Clocks Gains in Fiscal Q4 Consolidated Net Profit MT
Transcript : Sun Pharmaceutical Industries Limited, Q4 2024 Earnings Call, May 22, 2024
Chart Sun Pharmaceutical Industries Ltd.
More charts
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,586 INR
Average target price
1,623 INR
Spread / Average Target
+2.33%
Consensus
  1. Stock Market
  2. Equities
  3. SUNPHARMA Stock
  4. News Sun Pharmaceutical Industries Ltd.
  5. Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical